Innate Pharma (IPHA) Other Non-Current Assets (2017 - 2026)
Innate Pharma (IPHA) posted Other Non-Current Assets of $1.02 million for the quarter ended Jun 30, 2026, up 56.1% from $653,141 a year earlier.
Powered by 
Analysis
Innate Pharma (IPHA) Other Non-Current Assets (2017 - 2026) Analysis & Trends
As of Dec 31, 2025, Innate Pharma's Other Non-Current Assets came in at $1.07 million, up 71.9% from the prior year.
- Annual Other Non-Current Assets shows a five-year compound annual growth rate of 44.8% (years ended Dec 2020 to Dec 2025).
- In prior years, Innate Pharma's Other Non-Current Assets was $622,345 in the year ended Dec 31, 2024 (+561.3%), $94,109 in the year ended Dec 31, 2023 (-40.1%), $157,039 in the year ended Dec 31, 2022 (-7.2%) and $169,308 in the year ended Dec 31, 2021 (+0.9%).
- Quarterly Other Non-Current Assets has run from a low of $91,535 in the quarter ended Jun 30, 2024 to a high of $1.1 million in the quarter ended Dec 31, 2025 over five years.
- The strongest year-over-year quarter for Other Non-Current Assets in the past five years was the quarter ended Jun 30, 2025, with growth of 613.5%; the weakest was the quarter ended Jun 30, 2023, with a decline of 41.1%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.90 Bn | 1,105.48 Bn | 19.71 Bn | 7.48 Bn |
| 2 | Johnson & Johnson | 617.06 Bn | 535.59 Bn | 17.26 Bn | 14.27 Bn |
| 3 | AbbVie | 501.38 Bn | 474.49 Bn | 12.70 Bn | 10.73 Bn |
| 4 | Merck | 367.41 Bn | 321.79 Bn | 12.21 Bn | 19.60 Bn |
| 5 | Novartis Ag | 297.92 Bn | 261.91 Bn | 11.24 Bn | 5.93 Bn |
| 6 | Astrazeneca | 261.31 Bn | 235.00 Bn | 12.86 Bn | - |
| 7 | Amgen | 236.29 Bn | 191.69 Bn | 7.24 Bn | 12.98 Bn |
| 8 | Gilead Sciences | 190.40 Bn | 164.60 Bn | 6.22 Bn | 4.75 Bn |
| 9 | Pfizer | 169.55 Bn | 116.19 Bn | 10.94 Bn | 9.94 Bn |
| 10 | Innate Pharma | 143.35 Mn | -63.85 Mn | - | 1.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.00 Mn |
| Dec 31, 2025 | 1.11 Mn |
| Jun 30, 2025 | 676,674.07 |
| Dec 31, 2024 | 598,353.74 |
| Jun 30, 2024 | 91,022.02 |
| Dec 31, 2023 | 96,293.27 |
| Jun 30, 2023 | 93,465.05 |
| Dec 31, 2022 | 158,845.22 |
| Jun 30, 2022 | 155,654.21 |
| Dec 31, 2021 | 167,610.41 |
| Jun 30, 2021 | 249,940.49 |
| Dec 31, 2020 | 180,808.48 |
| Jun 30, 2020 | 158,585.55 |
| Dec 31, 2019 | 99,700.45 |
| Dec 31, 2018 | 98,383.53 |
| Dec 31, 2017 | 132,553.13 |
API Access
Innate Pharma Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=IPHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "IPHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=IPHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();